The Journal of Maternal-Fetal & Neonatal Medicine, published by Taylor & Francis Ltd, is a leading multidisciplinary journal focused on the critical fields of obstetrics, gynecology, pediatrics, and perinatology. Since its inception, this journal has offered a platform for the dissemination of pioneering research and innovative clinical practices, bridging knowledge gaps and informing the future of maternal and neonatal health. With a commendable 2023 impact factor that places it in the Q2 category of both Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health, it stands at the forefront of scientific discourse, attracting a global readership. The journal aims to provide high-quality articles that contribute significantly to patient care, clinical practices, and policy-making, ensuring relevance and applicability to both researchers and healthcare professionals. With comprehensive access options and an emphasis on the convergence of emerging research trends, the Journal of Maternal-Fetal & Neonatal Medicine remains an invaluable resource for anyone dedicated to advancing the health of mothers and their newborns.

HYPERTENSION IN PREGNANCY is a leading academic journal dedicated to the critical study of hypertensive disorders during pregnancy, a crucial area of maternal and fetal health. Published by Taylor & Francis Inc, this journal boasts an Open Access policy since 2023, ensuring that research findings are freely accessible to a global audience. With an ISSN of 1064-1955 and E-ISSN of 1525-6065, it offers a platform for high-quality research and review articles since its inception in 1982. The journal holds a Q3 category ranking in both Internal Medicine and Obstetrics and Gynecology, reflecting its reputable standing within the scientific community. As of 2023, it ranks among the top quartile publications in its field, with Scopus ranking it 86/209 in Obstetrics and Gynecology and 83/167 in Internal Medicine. This journal aims to foster dialogue among researchers, clinicians, and policymakers regarding the management and implications of hypertension in pregnancy, promoting advancements in care and research methodologies. Located in Philadelphia, PA, it continues to be an invaluable resource for those invested in improving maternal health outcomes and advancing the field.

Obstetrician & Gynaecologist is a leading peer-reviewed journal dedicated to the field of obstetrics and gynecology, published by WILEY. With a strong focus on delivering high-quality research and insights, this journal serves as a vital resource for healthcare professionals, researchers, and students involved in women's health. Although it does not offer open access, the journal maintains a significant impact on clinical practices by publishing original research, reviews, and case studies that align with the latest advancements in obstetric and gynecological medicine. The ISSN for the journal is 1467-2561, and it can also be accessed through the E-ISSN 1744-4667. Located at 111 River St, Hoboken, NJ 07030-5774, the journal aims to enhance knowledge and foster dialogue among practitioners and researchers, thereby improving health outcomes for women worldwide.

Archives of Gynecology and Obstetrics is a prestigious scholarly journal published by Springer Heidelberg that serves as a significant platform for advancements in the fields of gynecology and obstetrics since its inception in 1987. With an ISSN of 0932-0067 and an E-ISSN of 1432-0711, the journal has demonstrated consistent growth and impact, achieving a commendable Q2 category ranking in both medicine and obstetrics and gynecology, as per the 2023 rankings. Located in Germany, the journal focuses on disseminating high-quality research and clinical studies that address contemporary issues in female reproductive health and obstetric practices. Although not fully open access, it ensures wide visibility and accessibility through various platforms. With a Scopus rank of #55 out of 209 in the medicine obstetrics and gynecology category, the journal plays a crucial role in shaping the discourse and innovation in women's health care, making it an essential resource for researchers, healthcare professionals, and students alike.

European Journal of Obstetrics & Gynecology and Reproductive Biology-X, published by ELSEVIER, serves as a pivotal platform in the fields of obstetrics, gynecology, and reproductive biology. With an ISSN of 2590-1613, this journal has developed a notable presence since its transition to Open Access in 2019, enabling wider dissemination of research findings and fostering collaboration across disciplines. Located in Amsterdam, Netherlands, this journal holds a commendable Q2 ranking in both Obstetrics and Gynecology and Reproductive Medicine categories for 2023, reflecting its impact and relevance in the scientific community. Researchers and practitioners can access cutting-edge studies and reviews, contributing to advancements in reproductive health and clinical practices. With a focus on innovative research and evidence-based practices, the European Journal of Obstetrics & Gynecology and Reproductive Biology-X is committed to bridging the gap between laboratory discoveries and the application in clinical settings, making it an essential resource for those dedicated to enhancing reproductive health outcomes.

Welcome to the Journal of Fetal Medicine, a leading publication dedicated to the progress of research in the field of fetal health and medicine. Published by Thieme Medical and Scientific Publishers Pvt Ltd, this journal serves as a vital resource for professionals, researchers, and students alike, offering insights into the latest advancements, methodologies, and best practices in fetal medicine. With ISSN 2348-1153 and E-ISSN 2348-8859, the journal aims to provide an international platform for sharing valuable findings and clinical practices to improve outcomes for both mothers and their unborn children. While the journal is not open access, it ensures the dissemination of high-quality peer-reviewed content, promoting knowledge exchange across various subspecialties within fetal medicine. The Journal of Fetal Medicine is poised to impact the field significantly, fostering innovation and collaboration among its readership.

Reproductive Medicine is an esteemed open-access journal published by MDPI, focusing on the latest research and advances in reproductive health, fertility, and assisted reproductive technologies. With its E-ISSN of 2673-3897, the journal aims to provide a platform for researchers, clinicians, and healthcare professionals to disseminate their findings, share innovative practices, and engage in scholarly discourse. Situated in Basel, Switzerland, Reproductive Medicine emphasizes a multidisciplinary approach, exploring biological, clinical, and psychological aspects of reproductive health. Although the journal is in the early stages of establishing metrics such as H-index and Scopus rankings, its open-access model enhances accessibility, allowing for a broad dissemination of knowledge. Committed to fostering advancements in the field, Reproductive Medicine is essential for those seeking to stay at the forefront of reproductive health research.

Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.

Pathologie is a distinguished academic journal published by Springer Heidelberg, dedicated to advancing the field of pathology and forensic medicine. With an ISSN of 2731-7188 and an E-ISSN of 2731-7196, this journal serves as a vital platform for researchers, professionals, and students to disseminate innovative findings and insights. Currently ranked in the Q3 category of pathology and forensic medicine according to the 2023 metrics, Pathologie reflects a commitment to quality and relevance in a dynamic research landscape. Despite its relatively recent establishment from 2022, the journal is gaining traction with a Scopus rank of 139 out of 208 in its category, positioning itself as an emerging resource within the academic community. While it operates under a subscription model, the importance of the journal lies in its objective to facilitate the exploration of diverse pathological processes and enhance forensic methodologies, ultimately improving clinical outcomes and investigative practices. As it continues to grow, Pathologie stands poised to impact the pathology domain significantly.

Maternal-Fetal Medicine is a pivotal open-access journal dedicated to advancing the field of reproductive health, encompassing both obstetrics and pediatrics. Published by Lippincott Williams & Wilkins, this journal has been providing a platform for groundbreaking research and comprehensive reviews since its transition to open access in 2019. With an ISSN of 2096-6954 and E-ISSN 2641-5895, it aims to disseminate high-quality findings that inform clinical practice and improve maternal and child health outcomes. The journal operates within the United States and is strategically positioned in Q3 of both the Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health categories according to the 2023 evaluation metrics. Despite its relatively recent establishment, Maternal-Fetal Medicine is committed to addressing essential issues and innovations in maternal-fetal health, fostering a collaborative environment for researchers, clinicians, and educators. It serves as a vital resource for those committed to pushing the boundaries of knowledge in this critical area of healthcare.